| III-42 Martin Johnson Exposure response relationship for interstitial lung disease (ILD) events following osimertinib treatment Thursday 09:50-11:20 |
| III-42 Martin Johnson Exposure response relationship for interstitial lung disease (ILD) events following osimertinib treatment Thursday 09:50-11:20 |